
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SIRT5 promotes non-small cell lung cancer progression by reducing FABP4 acetylation level
Zhen Li, Dongping Yu, Ning Wang, et al.
Neoplasma (2022) Vol. 69, Iss. 04, pp. 909-917
Open Access | Times Cited: 11
Zhen Li, Dongping Yu, Ning Wang, et al.
Neoplasma (2022) Vol. 69, Iss. 04, pp. 909-917
Open Access | Times Cited: 11
Showing 11 citing articles:
Sirtuins, resveratrol and the intertwining cellular pathways connecting them
Anca Ungurianu, Anca Zanfirescu, Denisa Margină
Ageing Research Reviews (2023) Vol. 88, pp. 101936-101936
Closed Access | Times Cited: 50
Anca Ungurianu, Anca Zanfirescu, Denisa Margină
Ageing Research Reviews (2023) Vol. 88, pp. 101936-101936
Closed Access | Times Cited: 50
Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation
Caicun Zhou, Zhong Ren, Lei Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Caicun Zhou, Zhong Ren, Lei Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Emerging roles of mitochondrial sirtuin SIRT5 in succinylation modification and cancer development
Z. J. Ke, Kaikai Shen, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Z. J. Ke, Kaikai Shen, Li Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
SIRT5: a potential target for discovering bioactive natural products
Yuwei Xie, Ning Cai, Xiaohua Liu, et al.
Journal of Natural Medicines (2025)
Open Access
Yuwei Xie, Ning Cai, Xiaohua Liu, et al.
Journal of Natural Medicines (2025)
Open Access
Role of SIRT5 in cancer. Friend or Foe?
Francisco Alejandro Lagunas‐Rangel
Biochimie (2023) Vol. 209, pp. 131-141
Closed Access | Times Cited: 8
Francisco Alejandro Lagunas‐Rangel
Biochimie (2023) Vol. 209, pp. 131-141
Closed Access | Times Cited: 8
Oxyberberine suppressed the carbon tetrachloride-induced liver fibrosis by inhibiting liver inflammation in a sirtuin 3-dependent manner in mice
Sicheng Zhao, Jidan Li, Xiaoxiao Xing, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109876-109876
Closed Access | Times Cited: 4
Sicheng Zhao, Jidan Li, Xiaoxiao Xing, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109876-109876
Closed Access | Times Cited: 4
New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studies
Ji Deng, Zemin Liu, Kai-Rong Zhu, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106487-106487
Closed Access | Times Cited: 3
Ji Deng, Zemin Liu, Kai-Rong Zhu, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106487-106487
Closed Access | Times Cited: 3
PARP9 knockdown confers protection against chemoresistance and immune escape of breast cancer cells by blocking the PI3K/AKT pathway
Tao Hong, Dingxiang Dong, Jun Li, et al.
Archives of Medical Science (2023) Vol. 20, Iss. 4, pp. 1228-1248
Open Access | Times Cited: 3
Tao Hong, Dingxiang Dong, Jun Li, et al.
Archives of Medical Science (2023) Vol. 20, Iss. 4, pp. 1228-1248
Open Access | Times Cited: 3
Identification of key genes and biological pathways in chronic obstructive pulmonary disease using bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Emerging role of sirtuins in non‑small cell lung cancer (Review)
Min Zhou, Wei Lin, Renfu Lu
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access
Min Zhou, Wei Lin, Renfu Lu
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access
Lidocaine inhibits the lung cancer progression through decreasing the HIST1H2BL levels via SIRT5 mediated succinylation
Xuan Chen, Zhenbin Li, YI Xiang-jun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Xuan Chen, Zhenbin Li, YI Xiang-jun, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access